Pharmaceutical expenditure is rising globally. Most high-income countries have exercised
pricing or purchasing strategies to address this pressure. Low-and middle-income countries …

Background Consumer moral hazard refers to an increase in demand for health services or
a decrease in preventive care due to insurance coverage. This phenomenon as one of the …

Background Countries with similar health systems but different medicines policies might
result in substantial medicines usage differences and resultant outcomes. The literature is …

A major goal of The Patient Protection and Affordable Care Act is to broaden health care
access through the extension of insurance coverage. However, little attention has been …

Objective To assess the degree to which reimbursement prices in Australia and England
differ for a range of generic drugs, and to analyse the supply-and demand-side factors that …

Objective. To create and report survey-based indicators of the affordability of prescription
medicines for patients in Australia. Method. A cross-sectional study of 1502 randomly …

In this chapter, the international literature on affordable medicine prices and corresponding
pricing policies is reviewed. A broad range of sources is used: the academic peer-reviewed …

Objective. To assess patients' prescription medicine cost consciousness and explore the
implications of further cost sharing increases for affordability. Design and participants. A …

This paper describes developments in Australia's regulation of prescription drug marketing
and promotion. We show that the pharmaceutical industry has proved less capable of …

Σκοπός: Σκοπός της εργασίας είναι η επίδραση της πολιτικής του φαρμάκου στην αγορά και
η σημασία της φαρμακοεπαγρύπνησης για την ασφάλεια των πολιτών. Η …